Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults
View ORCID ProfileHelen Ward, View ORCID ProfileGraham Cooke, View ORCID ProfileChristina Atchison, View ORCID ProfileMatthew Whitaker, Joshua Elliott, Maya Moshe, Jonathan C Brown, Barney Flower, Anna Daunt, View ORCID ProfileKylie Ainslie, View ORCID ProfileDeborah Ashby, View ORCID ProfileChristl Donnelly, View ORCID ProfileSteven Riley, View ORCID ProfileAra Darzi, View ORCID ProfileWendy Barclay, View ORCID ProfilePaul Elliott, for the REACT study team
doi: https://doi.org/10.1101/2020.10.26.20219725
Helen Ward
1School of Public Health, Imperial College London, London, UK
4Imperial College Healthcare NHS Trust, London, UK
5MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK
Graham Cooke
2Department of Infectious Disease, Imperial College London, London, UK
4Imperial College Healthcare NHS Trust, London, UK
Christina Atchison
1School of Public Health, Imperial College London, London, UK
4Imperial College Healthcare NHS Trust, London, UK
Matthew Whitaker
1School of Public Health, Imperial College London, London, UK
Joshua Elliott
1School of Public Health, Imperial College London, London, UK
Maya Moshe
2Department of Infectious Disease, Imperial College London, London, UK
Jonathan C Brown
2Department of Infectious Disease, Imperial College London, London, UK
Barney Flower
2Department of Infectious Disease, Imperial College London, London, UK
4Imperial College Healthcare NHS Trust, London, UK
Anna Daunt
2Department of Infectious Disease, Imperial College London, London, UK
4Imperial College Healthcare NHS Trust, London, UK
Kylie Ainslie
1School of Public Health, Imperial College London, London, UK
5MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK
Deborah Ashby
1School of Public Health, Imperial College London, London, UK
Christl Donnelly
1School of Public Health, Imperial College London, London, UK
6Department of Statistics, University of Oxford
Steven Riley
1School of Public Health, Imperial College London, London, UK
5MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK
Ara Darzi
3Institute for Global Health Innovation Imperial College London, London, UK
4Imperial College Healthcare NHS Trust, London, UK
Wendy Barclay
2Department of Infectious Disease, Imperial College London, London, UK
Paul Elliott
1School of Public Health, Imperial College London, London, UK
4Imperial College Healthcare NHS Trust, London, UK
7MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK
8Health Data Research (HDR) UK London at Imperial College London, London, UK
9Dementia Research Institute at Imperial College London, London, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The original datasets generated or analysed, or both, during this study are not publicly available because of governance restrictions and the identifiable nature of the data.
Posted October 27, 2020.
Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults
Helen Ward, Graham Cooke, Christina Atchison, Matthew Whitaker, Joshua Elliott, Maya Moshe, Jonathan C Brown, Barney Flower, Anna Daunt, Kylie Ainslie, Deborah Ashby, Christl Donnelly, Steven Riley, Ara Darzi, Wendy Barclay, Paul Elliott, for the REACT study team
medRxiv 2020.10.26.20219725; doi: https://doi.org/10.1101/2020.10.26.20219725
Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults
Helen Ward, Graham Cooke, Christina Atchison, Matthew Whitaker, Joshua Elliott, Maya Moshe, Jonathan C Brown, Barney Flower, Anna Daunt, Kylie Ainslie, Deborah Ashby, Christl Donnelly, Steven Riley, Ara Darzi, Wendy Barclay, Paul Elliott, for the REACT study team
medRxiv 2020.10.26.20219725; doi: https://doi.org/10.1101/2020.10.26.20219725
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2637)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12211)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4087)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2646)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3862)
- Nursing (209)
- Nutrition (577)
- Oncology (2022)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1398)
- Respiratory Medicine (871)
- Rheumatology (404)
- Sports Medicine (342)
- Surgery (444)
- Toxicology (52)
- Transplantation (185)
- Urology (165)